EVGN•benzinga•
Aegis Capital Maintains Buy on Evogene, Lowers Price Target to $8
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 12, 2022 by benzinga